Related Experiment Video
Updated: Sep 27, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
[Bioinformatics Analysis of Microarray Data in Myelodysplastic Syndrome Based on Gene Expression Omnibus Database]
Bing-Jie Ding1, Hu Zhou2, Liu Liu3
1Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|April 9, 2022
Summary
Bioinformatics analysis identified 112 differentially expressed genes (DEGs) in myelodysplastic syndromes (MDS). Key genes and pathways involved in immune response and cell signaling offer insights into MDS molecular mechanisms and potential targeted therapies.
Area of Science:
- Genomics
- Bioinformatics
- Hematology
Background:
- Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
- Understanding the molecular mechanisms underlying MDS is crucial for developing effective treatments.
Purpose of the Study:
- To identify key genes and explore molecular mechanisms in myelodysplastic syndrome (MDS) development using bioinformatics analysis.
- To provide a theoretical basis for clinical targeted therapy in MDS.
Main Methods:
- Downloaded and analyzed two MDS datasets from the Gene Expression Omnibus (GEO) database.
- Screened differentially expressed genes (DEGs) using GEO2R and performed functional annotation via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases.
- Identified key genes using Matthews correlation coefficient (MCC) and STRING database, and analyzed protein-protein interaction (PPI) networks with Cytoscape.
Main Results:
- Identified 112 DEGs (85 up-regulated, 27 down-regulated) in MDS.
- GO enrichment analysis revealed enrichment in immune response, cell membrane, and protein binding.
- KEGG pathway analysis highlighted primary immunodeficiency, hematopoietic cell lineage, B cell receptor signaling, Hippo signaling, and asthma.
- Identified 10 key node genes (e.g., CD19, IRF4, RAG1) within significant modules of the PPI network.
Conclusions:
- The identified key genes and signaling pathways enhance the understanding of MDS molecular mechanisms.
- These findings provide a foundation for developing targeted therapeutic strategies for MDS patients.
